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Summary.-The metabolism of 2-[14C]-folic acid, 2-[14C]-5-methyltetrahydrofolate
5-[14C]-methyltetrahydrofolate, and a mixture of 2-[14C]-folic acid and 3',5',7,9-[3H] -
folic acid has been studied in rats that were dosed with methotrexate (MTX) 24 h
before receiving the radioactive folate. Methotrexate increases urinary excretion of
radioactivity in rats given 2-[14C]-folic acid, but there was no significant increase in
urinary radioactivity in animals given 5-methyltetrahydrofolate. Animals dosed
with MTX had less of the dose in the liver, and excreted more of the dose via the
faeces. These results are consistent with the known biochemical effects of metho-
trexate. Experiments with a mixture of2-[14C]-folic acid and 3', 5',7,9-[3H]-folic acid
indicate that there is an increase in scission of the folate molecule following a dose
of MTX.
METHOTREXATE (MTX) is a folate
antagonist that has been used with some
success to treat neoplasms (Johns &
Bertino, 1973; Chabner et al., 1975). It is
known to be a potent inhibitor ofdihydro-
folate reductase (Bertino et al., 1965) and
its action as an antitumour agent is
thought to be due to this inhibition.
Little information is available on the
effect of MTX in the whole animal,
although its distribution and metabolism
have been investigated (Henderson et al.,
1965a,b) and much work has been carried
out on isolated cells or in vitro (Goldman,
1977). Barford et al. (1976) reported that
the effect of MTX on the metabolism of
[14C]-folic acid in the whole animal could
not simply be explained by inhibition of
the reduction of dihydrofolate by dihydro-
folatereductase, and thatMTX washaving
some other effect.
This paper describes the effect of MTX
on the distribution of 2-[14C]-folic acid,
2-[14C]-5-methyltetrahydrofolate, 5-[14C]-
methyltetrahydrofolate and a mixture of
2-[14C]-folic acid and 3',5',7,9-[3H]-folic
acid in the rat.
MATERIALS AND METHODS
Animals. Male Wistar rats (150-200 g
body wt) received oral doses of MTX,
10 mg/kg body wt or 100 mg/kg body wt. For
controlsanimals weredosed withwaterinstead
of MTX. Twenty-four hours later animals
were given doses of either 2-[14C]-folic acid
(76 jug/kg body wt), 2-[14C]-5 methyltetra-
hydrofolate (7 ,ug/kg body wt), 5-[14C]-
methyltetrahydrofolate (70 Htg/kg body wt)
or a mixture of 2-[14C]-folic acid and 3', 5',
7,9-[3]-folic acid (90 (Lg/kg body wt).
Animals were then housed in metabolism
cages (Jencons Metabowls, Jencons (Scien-
tific) Limited, Hemel Hempstead, Herts.)
designed for the separate collection of urine
and faeces. Twenty-four hours after being
dosed with radioactivity animals were killed
and the livers removed into ice-cold beakers.
Throughout all experiments animals were
allowed food and water ad libitum.
Measurement of total radioactivity in livers
faeces and urine samples. Livers and faeces
-were freeze-dried and then ground to give a
homogeneous powder. 100mg samples were
used to estimate total radioactivity as
described in Barford et al. (1977). Urine
samples were counted as described in Barford
& Blair (1978).MTX AND FOLATE METABOLISM
Preparationt ofliver extracts.-Liver extracts
were prepared as described in Barford et al.
(1977) to prevenit breakdown of folate poly-
glutamates.
Column chromatoygraphy.-Liver extracts
and urine samples were chromatographed on
DEAE cellulose and Sephadex G.15 as
described in Barford & Blair (1978).
Measurement of radioactivity in columnn
effluents.-Radioactivity in column effluents
was determined as described in Barford et al.
(1978).
Chernicals. All chemicals were of"Analar"
grade or its equivalent. 2-[141-folic acid.
sp. act. 50 mCi/mmol, 3',5',7,9-[3H]-folic
acid, sp. act. 100 mCi/mmol, and 5-[14C]-
methyltetrahydrofolate, sp. act.45mCi/mmol,
w%Nere obtained from the Radiochemical
Centre, Amersham, Bucks. Folates for cali-
bration purposes wAere prepared as described
in Barford et al. (1977). 2-[14]-5-methyl-
tetrahydrofolate was prepared from 2-[14C1-
folic acid. Six adult male Wistar rats
(200-250 g body wNt) were orally dosed writh
2-[14C]-folic acid (76 jtg/kg body wt). Animals
were housed in metabolism cages. Urine was
collected for 24 h after administration of the
radioactivity into flasks containing 5 ml of
0-05M phosphate buffer (pH 7 0) containing
500 (w/v) sodium ascorbate and 5 mg 00
(w/v) dithiothreitol. Urine samples were
pooled and chromatographed on DEAE
cellulose. The radioactive peak corresponding
to 2-[14C]-5-methyltetrahydrofolate w%as re-
moved and concentrated to a volume of
20 ml. This fraction was further purified by
chromatography on DEAE cellulose and the
peak corresponding to 2-[L4C]-5-methyltetra-
hydrofolate removed and chromatographed
on Sephadex G.15. The 2-[14C]-5-methyl-
tetrahydrofolate peak was removed from
Sephadex G.15 and stored frozen in 2%0 w/v
sodium ascorbate unitil required. This pro-
cedure produces the naturally occurring
diastereo-isomer of5-methyltetrahydrofolate.
RESULTS AND DISCUSSION
Recovery of radioactivity in liver andfaeces
Quantitative analyses of livers showed
that in animals in the control group 12a1%
of the dose of 2-[14C]-folic acid was re-
covered in the liver 24 h after administra-
tion of the dose (Table I). The recovery of
radioactivity in livers of animals dosed
with MTX was 4.30 after a dose of
10mg/kg body wt and 2-8% after a dose
of 100mg/kg body wt. These differences
are highly significant (P < 0001 in both
groups). Similar results were obtained
when animals were given 2-[14C]-5-
methyltetrahydrofolate 24 h after a dose
of MTX (100mg/kg body wt). Animals in
the control group retained 13.5% of the
radioactivity in the liver 24 h after the
dose and animals receiving MTX retained
5.50% of the dose (P<0001). In all of
these groups of animals the liver radio-
activity, extracted to prevent breakdown
of polyglutamates, showed a single peak
chromatographing as a polyglutamate on
both Sephadex G.15 and DEAE cellulose.
Quantitative analysis of faeces showed
that MTX (100 mg/kg) decreased the
uptake of the folates from the intestine
(P < 001 for animals dosed with 2-[14C]-
folic acid, P<0 05 for animals dosed
with 5-[14C]-methyltetrahydrofolate and
P < 010 for animals dosed with 2-[14C]-5-
methyltetrahydrofolate (Table II).
TABLE I.-Percentage recovery of radioactivity in the livers of rats receiving oral doses of
[14C]-folates 24 h after oral doses of MTX. For controls, animals were dosed with water
24 h before receiving [14C]-folate. Number of animals in brackets
Animals received doses of:
Folate
2-[14C]-folie aci(d (76 pLg/kg bo(ly wt)
2-[14C]-5-methyltetrahydlrofolate
(7 ,ug/kg body wt)
W\ater
(controls)
Alean S.e.
12-1 3-8 (8)
13-5 0-8 (2)
AITX
(10 mg/lkg body wt) (100 mg/kg body wt)
r- -Al
Mean S.e. AMean S.e.
4-3 1-4 (8) 2-8 1*1 (6)
5-5 1-5 (4)
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TABLE II.-Percentage recovery of radioactivity in thefaeces of rats receiving oral doses of
[14C]-folate 24 h after oral doses of MTX. Control animals were dosed orally with water
24 h before receiving [14C]-folate. Number of animals in brackets
Animals received doses of:
Folate
2-[L4C]-folic acid (76 ,Fg/kg body wt)
5-[14C]-5-methyltetrahydrofolate
(70 tg/kg body wt)
2-[14C]-5-methyltetrahydrofolate
(7 ,ug/kg bodywt)
Water MTX
(controls) , ..
r A 10 mg/kg body wt 100 mg/kg body wt
Mean S.e. >,t
Mean S.e. Mean S.e.
36-3 7-9 (8) 42-5 12-6 (8) 48-4 4-8 (6)
23-9 3-7 (4) 330 1-8 (4)
34-4 4-5 (4) 38-4 2-2 (6)
TABLE III. Percentage recovery of dosed radioactivity in urine samples of rats receiving
oral doses of [14C]-folates 24 h after oral doses ofMTX. Control animals were dosed with
water 24 h before the dose of [14C]-folates. For details see text. Number of animals in
brackets
Animals received doses of:
Folate
2-[14C]-folic acid
(76 fig/kg body wt)
2-[14C]-5-methyl-
tetrahydrofolate
(7 jig/kg body wt)
Water
(controls)
0-6 h 6-24 h
t--
Mean S.e. Mean S.c.
8-4 18 9.9 2-8
(8)
0-24 h
Mean S.e.
17-4 1-2
(4)
Recovery of radioactivity in urine samples
The recovery of radioactivity in urine
samples over the 24h period is shown in
Table III. Control animals excrete 8.5%
of a dose of 2-[14C]-folic acid in urine in
6 h. When 2-[14C]-folic acid is given after
MTX significantly more radioactivity is
excreted in urine in the first 6 h after
administration of the dose. The urinary
excretion of radioactivity being 22.2% of
the dose (P < 0O001) after a dose of MTX
of 10 mg/kg body wt. Much of this in-
crease in urinary radioactivity is due to
excretion of unmetabolized folic acid
(Table IV) presumably caused by inhibi-
tion of dihydrofolate reductase. Also,
animals that have been dosed with MTX
excrete less of the urinary folates as
5-methyltetrahydrofolates.
There was no significant difference in
r~ ~ ~ ~ M 10 mg/kg body wt
0-6 h 6-24 h
Mean S.e. Mean S.e.
22-2 2-6 9-2 2-3
(8)
ll- ~ ~ --T
100 mg/kg body wt
0-6 h 6-24 h
C- -
Mean S.e. Mean S.e.
21-2 2-6 11*8 2-3
(6)
0-24 li
Mean S.e.
19-8 0-8
(6)
TABLE IV.-Radioactivity in 24h urine
samples associated with folic acid and
5-methyltetrahydrofolate in control ani-
mals and animals receiving oral doses of
MTX (10mgand 100 mg/kg bodywt). For
details see text. For numbers of animals
see Table III
Total
in urine.
% of
Animals dose
Controls 18-3
MTX 10 mg. 31-4
MTX100mg. 33-0
Folic
acid.
% of
dose
7-7
20-6
29-0
5 Methyl-
tetrahydra-
folate.
0/ ofdose
4-4
2-0
0-6
recovery of radioactivity in urine and in
urinary metabolites between normal rats
dosed with 2-[14C]-5-methyltetrahydro-
folate and rats dosed with 2-[14C]-5-
methyltetrahydrofolate 24 h after a dose
of MTX. In both groups of animals the
major urinary folate was 5-methyltetra-
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hydrofolate. WVhen animals were given a
mixture of 2-[14C]-folic acid and 3',5',7,9-
[3H]-folic acid both 3H and 14C were
recovered in urine samples. Quantitative
analysis showed that there was no signifi-
cant difference between the recovery of
3H and 14C in these urine samples, but
chromatography of urine samples showed
the presence of a metabolite labelled with
3H only that chromatographed with
p-aminobenzoate or p-acetamidobenzoate
(Connor et al., 1979). Analysis of the urine
figures showed that the excess of 3H over
14C in the fractions associated with re-
duced folate was increased in animals
dosed with MTX (Table V).
TABLE V. Percentage recovery of radio-
activity in 0-24h urine samiples asso-
ciated with non-folic acid peaks
% radio-
aetivity in
ur ine
less folic
aci(l peak % 3H
,- -A_- , over
33H 14C 14C
CoIntrols 1:39 7-9 76
AITX 10 mg/kg bolyxvt 17-6 8-8 100
MTX 100mg/kg bodly wt 10-4 4 0 160
MTX decreases the amount of folate
polyglutamate retained in rat livers when
animals are dosed with 2-[14C]-folic acid
or 2-[14]-5-methyltetrahydrofolate 24 h
after being dosed with MTX. There are
several possible explanations for this
decrease in liver polyglutamate. The blood
levels of the radioactive folate may be
decreased because of decreased absorption
of the label from the intestine. MTX may
be decreasing the uptake ofradiolabel into
the liver, or it could cause decreased
retention in the liver because the folate
that entered the liver was metabolized less
well to polyglutamate, or polyglutamate
catabolism was increased. Lei et al. (1977)
and Lucas et al. (1978) have shown that
MTX does not affect folic acid uptake
from the intestine in vitro, but has a
marked effect ifgiven 24 h before removal
of the intestine for in vitro experiments.
That decreased intestinal absorption
could contribute to the reduced liver
folate polyglutamate formation observed
in these experiments is supported by the
increased faecal recovery of radioactivity
after oral 2-[14C']-folic acid, 2-[14C]-5-
methyltetrahydrofolate and 5-[14CI-5-
methyltetrahydrofolate (Table II).
McGuire et al. (1979) have shown that
tetrahydrofolate is a substrate for pteroyl-
polyglutamate synthetase while folic acid
is not. The inability of the liver to convert
large quantities of 2-[14C]-folic acid to
tetrahydrofolate and thus to polyglut-
amate may explain the decreased retention
of radioactivity in the liver when radio-
labelled folic acid is given after a dose of
MTX. McBurney & Whitmore (1974) have
suggested that conversion to polyglut-
amates serves to trap the folate mono-
glutamates that are transported into cells.
MTX also decreases the retention ofradio-
activity in the liver when given 24 h before
a dose of 2-[14C]-5-methyltetrahydro-
folate, which is a poor substrate for
pteroylpolyglutamate synthetase (McCGuire
et al., 1979). 5-methyltetrahydrofolate
must lose the methyl group in vivo before
it can be converted to a polyglutamate
(Lavoie et al., 1974), but no reduction step
is necessary. MTX could reduce the levels
of liver polyglutamate after a dose of
2-[14C]-5-methyltetrahydrofolate at a step
other thaninhibiting thereduction ofdihy-
drofolate reductase, probably by inhibiting
liver folate transport, or by accelerating
the catabolism of liver folate polyglut-
amates (Connor et al., 1979) or both. That
folate catabolism can occur after MTX is
shown by the scission products after
administration of mixed 3H- and 14(1
labelled folic acid (Barford et al., 1977).
The results presented in this paper demon-
strate an increase in scission after MTX
administration, possibly by inhibiting
reduction of dihydrofolate to tetrahydro-
folate by dihydrofolate reductase, or by
inhibition of dihydropteridine reductase,
an enzyme which may maintain tetra-
hydrofolates in the fully reduced state
(Pollock & Kaufman, 1978). Barford &
Blair (1978) demonstrated a decrease in
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scission of the folate molecule in animals
with a Walker 256 tumour.
The urinary folate results demonstrate
that less of the dose of radiolabelled folic
acid enters the folate pool in animals that
have been dosed with MTX, but that more
of the folate that enters the pool under-
goes scission. The large excretion of folic
acid is most probably due to failure of the
radiolabelled folic acid to enter the folate
pool because of inhibition of dihydro-
folate reductase by MTX. There is no
significant difference in urinary recovery
of radioactivity between control animals
and animals dosed with MTX when
animals are given 2-[14C]-5-methyltetra-
hydrofolate. Animals that have been dosed
with 2-[14C]-folic acid excrete both 5-
methyltetrahydrofolate and 10-formyl-
folates in urine samples.
The results presented here demonstrate
that MTX affects the uptake and retention
of labelled oral folates in the whole
animal, and reduces the size of the liver
folate polyglutamate pool which has an
essential primary coenzyme function in
purine andpyrimidine biosynthesis (Rowe,
1978) and thus the therapeutic effect may
not be due solely to inhibition of dihydro-
folate reductase, but also to changes in
distribution of folates in the animal. This
paper describes for the first time a reduc-
tion in incorporation offolates in the whole
animal into an essential coenzyme pool by
the action of MTX, and demonstrates an
increase in scission of the folate molecule
after MTX administration.
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